Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2023 Earnings Call Transcript November 14, 2022
Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.06, expectations were $-0.18.
Operator: Good afternoon, ladies and gentlemen, and welcome to the Aytu BioPharma Fiscal 2023 Q1 Results Call. At this time, all participants are placed on a listen-only mode and the floor for questions and comments after the presentation. It is now my pleasure to turn the floor over to your host, Roger...
